Analystreport

Soleno Therapeutics (NASDAQ:SLNO) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.

Soleno Therapeutics, Inc.  (SLNO) 
Last soleno therapeutics, inc. earnings: 5/13 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview